Home

arrow iconNewsarrow iconarrow icon

Minnesota Bill for Infertility Treatments Expands Insurance Coverage by 2027

Minnesota Bill for Infertility Treatments Expands Insurance Coverage by 2027

The Minnesota bill for infertility treatments mandates comprehensive insurance coverage for diagnosis, IVF, and fertility preservation across public and private health plans. Set for implementation in 2027, the legislation expands access, modernises infertility definitions, and ensures cost-sharing protections to make reproductive healthcare more equitable.

By FertilityIn

10 Mar 2026

4 min read

Minnesota Legislature

Minnesota Legislature

Major Takeaways from SF 1961

  • Mandatory Coverage Expansion: All health plans in Minnesota that provide maternity benefits must now include comprehensive coverage for the diagnosis and treatment of infertility, as well as standard fertility preservation services.
  • Public Program Integration: The legislation extends these requirements to Medical Assistance and MinnesotaCare, ensuring that low-income residents have access to the same reproductive technologies as those with private insurance.
  • Modernised Definition of Infertility: The bill defines infertility not only by the traditional failure to conceive after 6 or 12 months but also by a person’s inability to reproduce as a single individual or with a partner without medical intervention.
  • Clinical Standards and Limits: Coverage includes unlimited embryo transfers and up to four completed oocyte retrievals, adhering to professional guidelines from the American Society for Reproductive Medicine.
  • Cost-Sharing Parity: Health plans are prohibited from imposing deductibles, co-payments, or coinsurance for infertility treatments that are higher than those for maternity services.


Minnesota Legislative Shift Promises Comprehensive Fertility Access by 2027

The landscape of reproductive healthcare in the Midwest is poised for a significant transformation following the advancement of SF 1961. This Minnesota bill for infertility treatments seeks to eliminate the financial and diagnostic barriers that have historically hindered family-building for thousands of residents. By mandating that any health plan offering maternity benefits must also cover infertility care, the state is moving toward a model where reproductive medicine is treated as a fundamental component of healthcare.


A primary pillar of the legislation is its commitment to healthcare equity. Under the new requirements, the state’s public health programs Medical Assistance and MinnesotaCare, will be required to cover infertility diagnosis, treatment, and preservation services. This move is designed to ensure that a resident's socioeconomic status does not dictate their ability to access advanced medical interventions like IVF or egg freezing.


The Minnesota bill for infertility treatments also addresses the needs of patients facing "iatrogenic" infertility, requiring coverage for preservation services when a medical treatment, such as chemotherapy, poses a risk to future fertility.


The bill’s inclusive definition of infertility marks a departure from restrictive older statutes. It recognises infertility based on a patient’s medical and reproductive history or their inability to reproduce as a single individual or with a partner, effectively broadening access for the LGBTQ+ community and single parents by choice. Clinically, the mandate requires that treatments align with the professional standards set by the American Society for Reproductive Medicine. While the bill allows insurance providers to cap completed oocyte retrievals at four, it mandates unlimited embryo transfers, prioritising the most effective path to a live birth.


To protect patients from predatory plan designs, the legislation includes strict cost-sharing protections. Health plans are forbidden from applying waiting periods, referral requirements, or benefit maximums to infertility care that do not also apply to standard maternity coverage. This ensures that the Minnesota bill for infertility treatments provides meaningful financial relief rather than just theoretical access.


The implementation of these changes is scheduled for January 1, 2027, for all plans issued or renewed on or after that date. To assist with the transition, the state has established a reimbursement framework where the commissioner of commerce will use general fund appropriations to defray the additional costs incurred by health plan companies. This legislative framework represents a systemic effort to integrate fertility care into the standard continuum of medical services in Minnesota

6 views

Share

FertilityIn

Send Enquiry for this Story

Related Articles

Luna and Kindbody Partner to Advance Data-Driven Intelligence in Fertility Care

Luna and Kindbody Partner to Advance Data-Driven Intelligence in Fertility Care

Luna and Kindbody are redefining Intelligence in Fertility Care through a strategic partnership that integrates wearable biomarker tracking into clinical pathways. By capturing real-time physiological data, the collaboration enables personalised insights, enhances decision-making, and creates a more connected, data-driven fertility journey for patients and care providers alike.

ART

1 min read

Sapyen and Avenues Launch At-Home Fertility Diagnostics in UK

Sapyen and Avenues Launch At-Home Fertility Diagnostics in UK

Sapyen and Avenues launch at-home fertility diagnostics, introducing a couple-first testing model in the UK. By integrating semen analysis and AMH testing into early care, this approach reduces clinic visits, accelerates diagnosis, and ensures balanced fertility evaluation, transforming how patients begin their reproductive health journey.

ART

1 min read

Nexpring Health Invests in Technology for PCOS-Related Infertility

Nexpring Health Invests in Technology for PCOS-Related Infertility

Nexpring Health has invested in May Health to accelerate the development of the Anavi™ System, a novel device designed to treat PCOS-Related Infertility. The technology aims to restore ovulation through a single office-based procedure, expanding treatment options for millions of women affected by polycystic ovary syndrome.

ART

1 min read

INVO Fertility to Introduce Time-Lapse Incubation Technology to Enhance IVF Success Rates and Patient Outcomes

INVO Fertility to Introduce Time-Lapse Incubation Technology to Enhance IVF Success Rates and Patient Outcomes

INVO Fertility would be introducing time-lapse incubation technology at its Wisconsin clinic, hence offering high-quality lab care, creative patient solutions, and advanced embryo monitoring for improved fertility results.

ART

1 min read

Industry Leaders to Transform Fertility Care in the U.S. Through Groundbreaking Partnership Making Treatment More Accessible

Industry Leaders to Transform Fertility Care in the U.S. Through Groundbreaking Partnership Making Treatment More Accessible

Costco, Sesame, and IVI RMA North America have announced strategic partnership to alter fertility care in the U.S. by removing biggest obstacles to care including high costs and limited access.

ART

1 min read

Carea Launches the Trying to Conceive - IVF/IUI Mode to Empower Women with Seamless and Reliable Digital Support

Carea Launches the Trying to Conceive - IVF/IUI Mode to Empower Women with Seamless and Reliable Digital Support

Carea has launched its Trying to Conceive - IVF/IUI mode to help women undergoing intricate fertility treatment with risks of inconsistent clinic continuity through continuous tracking and expert guidance.

ART

1 min read

Landing Page Image

Subscribe to our Newsletter

Stay updated with the latest news, expert insights, and exclusive offers delivered straight to your inbox. Join our community today!

Email Address